Experimental study of the action of COX-2 selective nonsteroidal anti-inflammatory drugs and traditional anti-inflammatory drugs in bone regeneration

Clinics

Volumn 61, Issue 3, 2006, Pages 223-230

  Tiseo, Bruno C ^a   Namur, Guilherme N ^a   De Paula, Emygdio J L ^a   Mattar Jr , Rames ^a   De Oliveira, Claudia R G C M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anti inflammatory agents; Bone regeneration; Fracture consolidation; Nonsteroidal; Osteotomy; Rats; Wistar

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; LACTONE; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB; SULFONE;

ANIMAL; ARTICLE; BONE REGENERATION; CALLUS; DRUG EFFECT; OSTEOTOMY; PATHOLOGY; RADIOGRAPHY; RAT; TIME; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BONE REGENERATION; BONY CALLUS; CYCLOOXYGENASE 2 INHIBITORS; DICLOFENAC; LACTONES; OSTEOTOMY; RATS; RATS, WISTAR; SULFONES; TIME FACTORS;

EID: 33745921483     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322006000300007     Document Type: Article

References (26)

1. ACR Clinical Guideline. Committee. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum. 1996;39:713-22.
2. Vabne JR Tah. Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nat New Biol. 1971;231:232-5.
3. Smith JB, Willis AL. Aspirin selectivity inhibits prostaglandin production in human platelets. Nat New Biol. 1971;231:235-7.
4. Sirois J, Simmons DL, Richards J. Hormonal regulation of messenger ribonucleic acid encoding a novel isoform of prostaglandin endoperoxide H synthase in rat pre-ovulatory follicles. Induction in vivo and in vitro. J Biol Chem. 1992;267:11586-92.
5. Kujubu DA, Fletcher BS, Vamum BC, Lim RW, Herschman HR. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem. 1991;266:12866-72.
6. Xie WL, Chipman JG, Robertson DL, Erikson RL, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA. 1991;88:2692-6.
7. Jones DA, Carlton DP, McIntyre TM, Zimmerman GA, Prescott SM. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem. 1993;268:9049-54.
8. Luong C, Miller A, Bamett J, Chow J, Ramesha C, Browner MF. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nat Struct Biol. 1996;11:927-33.
9. Kurumbail RG, Stevens AM, Glierse JK, McDonald JJ, Stegeman RA, Pak JY, et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature. 1996;384:644-8.
10. Maciel FMB. Expressão da ciclooxigenase-2 induzida pelo hormônio paratireóide em osteoblastos humanos em cultura [Thesis]. São Paulo: Faculdade de Medicina, Universidade de São Paulo; 1997.
11. Herschrnan HR. Prostaglandin synthase 2. Biochim Biophys Acta 1996;1299:125-40.
12. Smith WL, Marnett LJ. Prostaglandin endoperoxide synthase: structure and catalysis. Bioch Biophys Acta 1991;1083:1-17.
13. Masferrer JL, Zweifel BS, Seelbert K, Needeeman P. Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest. 1990;86:1375-9.
14. O'Bannion MK, Win VD, Young DA. Temporal and pharmacologic division of fibroblast cyclooxygenase expression into transcriptional and translational phases. Natl Acad Sci USA 1992;89:4888-92.
15. Vane JR, Botting RM. Anti-inflammatory drugs and their mechanism of action. Inflamm Res. 1998;47(Suppl 12):578-87.
16. Whittle BJ, Higgs GA, Eakins KE, Moncada S, Vane JR. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature 1980;284:271-3.
17. Moncada S, Gryglewski R, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 1976;263:663-5.
18. Lyons-Giordano B, Prata MA, Galbraith W, Davis GL, Arner EC. Interleukin-I differentially modulates chondrocyte expression of cyclooxygenase-2 and phospholipase A2. Exp Cell Res. 1993;206:58-62.
19. Berenbaum F, Jacques C, Thomas G, Corvol MT, Bereziat G, Masliah J. Synergistic effect of interleukin-l beta and tumor necrosis factor alpha on PGE2 production by articular chondrocytes does not involve PLA2 stimulation. Exp Cell Res. 1996;222:379-84.
20. Okada Y, Lorenzo JA, Freeman AM, Tomita M, Morham SG, Raisz LG, et al. Prostaglandin G/h synthase-2 is required for maximum formation of osteoclast-like cells in culture. J Clin Invest. 2000;105:823-32.
21. Weinnreb M, Suponitzky I, Keila S. Systemic administration of an anabolic dose of PGE2 in young rats increases the osteogenic capacity of bone marrow. Bone. 1997;20:521-6.
22. Suponitzky I, Weinnreb M. Differential effects of systemic prostaglandin E2 on bone mass in rat long bones and calvarie. J Endocrinol. 1998;156:51-7.
23. Forwood MR. Inducible cyclooxygenase (COX-2) mediates the induction of bone formation by mechanical loading in vivo. J Bone Miner Res. 1996;11:1688-93.
24. Duncan RL, Turner CH. Mechanotransduction and the functional response of bone and mechanical strain. Calcif Tissue Int. 1995;57:344-58.
25. Dekel S, Lenthall G, Francis MJ. Release of prostaglandin from bone and muscles after tibial fracture. An experimental study in rabbits. J Bone Joint Surg Br. 1981;63:185-9.
26. Zhang X, Schwars EM, Young DA, Puzas E, Rosier RN, O'Keefe RJ. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest. 2002;109:1405-15.